Two recent papers just published in 2018 have documented a dramatic rise in the prevalence of EoE to fect currently more than 1 in 1,000 people Eosinophilic Esophagitis (EoE) is often classified as a rare disease, with prevalence routinely reported as less than 60 cases per 100,000 in the population…. Read More
DEAR EUREOS MEMBER,
As president of EUREOS I’m delighted to invite you to the General Assembly 2018, taking place on October 21st, in Vienna. We have decided to host our annual meeting this year in a hotel in central Vienna.
The General Assembly will not only give you the opportunity to hear about EUREOS achievements during the last year, it will also serve as ideal communication platform to discuss current and future projects, further improving understanding in EoE and best patient care.
We would also like to invite you to the EUREOS EoE Clinical Trial Symposium, which will follow immediately after the General Assembly.
We conclude with a reception and informal dinner open to all our members and corporate members, which will allow us to further discuss these topics in a friendly atmosphere.
We are looking forward to an interesting and lively exchange with you in Vienna!
Gastroenterologist AMC Amsterdam
President EUREOS 2017-2019
16:30 – 17:30 EUREOS General Assembly 2018
17:30 – 18:30 EoE Clinical trial symposium
Chair: Arjan Bredenoord
Ethical considerations for EoE trials
Arjan Bredenoord, Amsterdam, The Netherlands
Inclusion criteria: PPI-REoE, plain EoE or refractory EoE?
Alfredo Lucendo, Tomelloso, Spain
Discussion of endpoints in EoE trials
Evan Dellon, Chapel Hill, USA
18:30 Informal dinner reception
DATE October 21st, 2018
VENUE Grand Ferdinand Schubertring 10-12 1010 Viennna